Peer Reviewed Journal
2024, Vol. 4, Issue 1, Part B
A review paper on Alzheimer's disease
Author(s): Chhakuli D Patil, Sakhshi S Sable, Chandrabhan B Patil, Sumesh D Patil and Rohit S Chinchore
Abstract: This article discusses the recent advances within the prognosis and remedy of Alzheimer sickness (advert). In latest years, the sizable advances had been made in the fields of genetics, neuroimaging, medical analysis, and staging of ad. One of the most vital recent advances in advert is our ability to visualise amyloid pathology in the residing human mind. The newly revised criteria for the diagnosis of ad dementia include the use for biomarkers as supportive proof for the underlying pathology. Guidelines for the accountable use of amyloid positron emission tomography (puppy) have been evolved, and the medical and financial implications of amyloid pet imaging are actively being explored. Our stepped forward know-how of the medical onset, progression, neuroimaging, pathologic capabilities, genetics, and other threat factors for advert influences the techniques to medical diagnosis and destiny therapeutic interventions.
Pages: 93-96 | Views: 334 | Downloads: 79
Download Full Article: Click Here
How to cite this article:
Chhakuli D Patil, Sakhshi S Sable, Chandrabhan B Patil, Sumesh D Patil, Rohit S Chinchore. A review paper on Alzheimer's disease. Nat J Pharm Sci 2024;4(1):93-96.
